|
1
|
Fialkow PJ, Janssen JW and Bartram CR:
Clonal remissions in acute nonlymphocytic leukemia: Evidence for a
multistep pathogenesis of the malignancy. Blood. 77:1415–1417.
1991.PubMed/NCBI
|
|
2
|
Mistry AR, Pedersen EW, Solomon E and
Grimwade D: The molecular pathogenesis of acute promyelocytic
leukaemia: Implications for the clinical management of the disease.
Blood Rev. 17:71–97. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nasr R, Guillemin MC, Ferhi O, Soilihi H,
Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M,
Lallemand-Breitenbach V, Gourmel B, et al: Eradication of acute
promyelocytic leukemia-initiating cells through PML-RARA
degradation. Nat Med. 14:1333–1342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dos Santos GA, Kats L and Pandolfi PP:
Synergy against PML-RARa: Targeting transcription, proteolysis,
differentiation, and self-renewal in acute promyelocytic leukemia.
J Exp Med. 210:2793–2802. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dombret H, Castaigne S, Fenaux P,
Chomienne C and Degos L: Induction treatment of acute promyelocytic
leukemia using all-trans retinoic acid. Controversies about dosage,
advantages and side-effect management. Leukemia. 8(Suppl 3):
S73–S75. 1994.PubMed/NCBI
|
|
6
|
Tomita A, Kiyoi H and Naoe T: Mechanisms
of action and resistance to all-trans retinoic acid (ATRA) and
arsenic trioxide (As2O3) in acute
promyelocytic leukemia. Int J Hematol. 97:717–725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilkinson KD: Ubiquitination and
deubiquitination: Targeting of proteins for degradation by the
proteasome. Semin Cell Dev Biol. 11:141–148. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goldberg AL: Protein degradation and
protection against misfolded or damaged proteins. Nature.
426:895–899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ciechanover A: Proteolysis: From the
lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol.
6:79–87. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ciechanover A: Intracellular protein
degradation: From a vague idea thru the lysosome and the
ubiquitin-proteasome system and onto human diseases and drug
targeting. Cell Death Differ. 12:1178–1190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ciechanover A and Schwartz AL:
Ubiquitin-mediated degradation of cellular proteins in health and
disease. Hepatology. 35:3–6. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pickart CM: Mechanisms underlying
ubiquitination. Annu Rev Biochem. 70:503–533. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schulman BA: Twists and turns in
ubiquitin-like protein conjugation cascades. Protein Sci.
20:1941–1954. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Komander D, Clague MJ and Urbé S: Breaking
the chains: Structure and function of the deubiquitinases. Nat Rev
Mol Cell Biol. 10:550–563. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komander D: Mechanism, specificity and
structure of the deubiquitinases. Subcell Biochem. 54:69–87. 2010.
View Article : Google Scholar
|
|
16
|
Amerik AY and Hochstrasser M: Mechanism
and function of deubiquitinating enzymes. Biochim Biophys Acta.
1695:189–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eletr ZM and Wilkinson KD: Regulation of
proteolysis by human deubiquitinating enzymes. Biochim Biophys
Acta. 1843:114–128. 2014. View Article : Google Scholar
|
|
18
|
Wilkinson KD: DUBs at a glance. J Cell
Sci. 122:2325–2329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nijman SM, Luna-Vargas MP, Velds A,
Brummelkamp TR, Dirac AM, Sixma TK and Bernards R: A genomic and
functional inventory of deubiquitinating enzymes. Cell.
123:773–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Love KR, Catic A, Schlieker C and Ploegh
HL: Mechanisms, biology and inhibitors of deubiquitinating enzymes.
Nat Chem Biol. 3:697–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Quesada V, Díaz-Perales A,
Gutiérrez-Fernández A, Garabaya C, Cal S and López-Otín C: Cloning
and enzymatic analysis of 22 novel human ubiquitin-specific
proteases. Biochem Biophys Res Commun. 314:54–62. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sowa ME, Bennett EJ, Gygi SP and Harper
JW: Defining the human deubiquitinating enzyme interaction
landscape. Cell. 138:389–403. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Shi M, Ren X, Wang X, Wang H, Liu G, Yuan
X, Zheng S, Yu L, Pan S, Song G, et al: A novel combination of
oridonin and valproic acid in enhancement of apoptosis induction of
HL-60 leukemia cells. Int J Oncol. 48:734–746. 2016. View Article : Google Scholar
|
|
25
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multi-dimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ley TJ, Miller C, Ding L, Raphael BJ,
Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr, Laird PW, Baty
JD, et al Cancer Genome Atlas Research Network: Genomic and
epigenomic landscapes of adult de novo acute myeloid leukemia. N
Engl J Med. 368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schweitzer K and Naumann M: CSN-associated
USP48 confers stability to nuclear NF-κB/RelA by trimming
K48-linked Ub-chains. Biochim Biophys Acta. 1853:453–469. 2015.
View Article : Google Scholar
|
|
29
|
Potu H, Peterson LF, Kandarpa M, Pal A,
Sun H, Durham A, Harms PW, Hollenhorst PC, Eskiocak U, Talpaz M, et
al: Usp9x regulates Ets-1 ubiquitination and stability to control
NRAS expression and tumorigenicity in melanoma. Nat Commun.
8:144492017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu WT, Huang KY, Lu MC, Huang HL, Chen
CY, Cheng YL, Yu HC, Liu SQ, Lai NS and Huang HB: TGF-β upregulates
the translation of USP15 via the PI3K/AKT pathway to promote p53
stability. Oncogene. 36:2715–2723. 2017. View Article : Google Scholar
|
|
31
|
Luo K, Li Y, Yin Y, Li L, Wu C, Chen Y,
Nowsheen S, Hu Q, Zhang L, Lou Z, et al: USP49 negatively regulates
tumori-genesis and chemoresistance through FKBP51-AKT signaling.
EMBO J. 36:1434–1446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xing C, Lu XX, Guo PD, Shen T, Zhang S, He
XS, Gan WJ, Li XM, Wang JR, Zhao YY, et al: Ubiquitin-specific
protease 4-mediated deubiquitination and stabilization of PRL-3 is
required for potentiating colorectal oncogenesis. Cancer Res.
76:83–95. 2016. View Article : Google Scholar
|
|
33
|
Cetkovská K, Šustová H and Uldrijan S:
Ubiquitin-specific peptidase 48 regulates Mdm2 protein levels
independent of its deubiquitinase activity. Sci Rep. 7:431802017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li S, Wang D, Zhao J, Weathington NM,
Shang D and Zhao Y: The deubiquitinating enzyme USP48 stabilizes
TRAF2 and reduces E-cadherin-mediated adherens junctions. FASEB J.
32:230–242. 2018. View Article : Google Scholar
|
|
35
|
Zhou A, Lin K, Zhang S, Ma L, Xue J,
Morris SA, Aldape KD and Huang S: Gli1-induced deubiquitinase USP48
aids glioblastoma tumorigenesis by stabilizing Gli1. EMBO Rep.
18:1318–1330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Uckelmann M, Densham RM, Baas R,
Winterwerp HH, Fish A, Sixma TK and Morris JR: USP48 restrains
resection by site-specific cleavage of the BRCA1 ubiquitin mark
from H2A. Nat Commun. 9:2292018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song G, Shi L, Guo Y, Yu L, Wang L, Zhang
X, Li L, Han Y, Ren X, Guo Q, et al: A novel PAD4/SOX4/PU.1
signaling pathway is involved in the committed differentiation of
acute promyelocytic leukemia cells into granulocytic cells.
Oncotarget. 7:3144–3157. 2016.
|
|
38
|
Song MS, Salmena L, Carracedo A, Egia A,
Lo-Coco F, Teruya-Feldstein J and Pandolfi PP: The
deubiquitinylation and localization of PTEN are regulated by a
HAUSP-PML network. Nature. 455:813–817. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schwickart M, Huang X, Lill JR, Liu J,
Ferrando R, French DM, Maecker H, O'Rourke K, Bazan F,
Eastham-Anderson J, et al: Deubiquitinase USP9X stabilizes MCL1 and
promotes tumour cell survival. Nature. 463:103–107. 2010.
View Article : Google Scholar
|
|
40
|
Espinosa L, Cathelin S, D'Altri T,
Trimarchi T, Statnikov A, Guiu J, Rodilla V, Inglés-Esteve J,
Nomdedeu J, Bellosillo B, et al: The Notch/Hes1 pathway sustains
NF-κB activation through CYLD repression in T cell leukemia. Cancer
Cell. 18:268–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Novak U, Rinaldi A, Kwee I, Nandula SV,
Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, et
al: The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated
by somatic mutations and genomic deletions in marginal zone
lymphomas. Blood. 113:4918–4921. 2009. View Article : Google Scholar : PubMed/NCBI
|
